To evaluate the frequency and characterize the clinical phenotype of patients positive for both neurofascin-155 and contactin-1 antibodies.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: